ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

VHIO: driving the development of pioneering cell therapies for non-responders to current immunotherapies

16/10/2019|Comments Off on VHIO: driving the development of pioneering cell therapies for non-responders to current immunotherapies

Functional RNA assays and the reliable ousting of clinically actionable BRCA1/2 variants

15/10/2019|Comments Off on Functional RNA assays and the reliable ousting of clinically actionable BRCA1/2 variants

Expert VHIO interviews during ESMO Congress 2019: discussing striking findings against colorectal, gastric, pancreatic, and prostate cancer

10/10/2019|Comments Off on Expert VHIO interviews during ESMO Congress 2019: discussing striking findings against colorectal, gastric, pancreatic, and prostate cancer

Innovative Medicines Initiative backs Immune-Imaging Consortium to more precisely match immunotherapeutics to individual patients

10/10/2019|Comments Off on Innovative Medicines Initiative backs Immune-Imaging Consortium to more precisely match immunotherapeutics to individual patients

See all news
BROWSE OUR PIs
Launch our Scientific Report 2018

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

Follow us:

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
FERO FOUNDATION’s ADVANCED MOLECULAR DIAGNOSTICS PROGRAM
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
“LA CAIXA” INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

VHIO -”la Caixa” Scientific Seminars Series –
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS